Framing the Knowledge of Therapeutics for Viral Hepatitis, edited by Drs. Raymond Schinazi and Eugene Schiff, was released in December 2005 and comprises 25 chapters detailing the advances and challenges in the field.

Approximately 520 million people, or 8% of the world's population, suffer from chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infection, making chronic viral hepatitis a major public health concern. While treatments exist for both infections, and a vaccine is available for HBV, there is no known cure for these devastating diseases. Within this book, the latest advances in cell systems and animal models, genetics, viral dynamics, drug discovery and development, pathogenesis and pertinent aspects of the natural history and clinical features of hepatitis B and C are detailed by world authorities and scientists on the front lines of research.

The editors seek to illuminate these recent advances, and to put them in perspective with regard to the challenges that still remain in this rewarding field of study. Framing the Knowledge of Therapeutics for Viral Hepatitis honors Dr. Baruch Blumberg, one of the truly great scientists of our time who won a Nobel Prize in Medicine for his discovery of the hepatitis B virus.

The Hepatitis B Foundation will receive 5% of the proceeds from sales of this work. Visit www.ihlpress.com for more information and to order your copy today!